Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép

Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.

4buQPuG7nuG7nEAyw5nhuqnhuqnEqOG7muG6peG6qnvhuqsyJOG7muG7knk8w5nhu5zhuq3DmeG7nDPhu7Dhuqvhu5zhuqs+YsOgQOG7nD17LGLhu5zhuqvhuq1d4buc4buXw73hu4bFqcahLeG7nsOa4bucPcOdYuG7nOG6q3s6NOG7nD3hurnhurNA4bucQFnhuqXhu5zhuqU+JeG6peG7kC8+4bue4buS4buQ4bql4bucQDLDmeG6qeG6qcSo4bua4bql4bunJMOZI+G7muG7knk84bumZuG7nOG7nuG7ni9Tw5Lhu5x5PMOZ4bucPeG7qOG7nEA+NeG7nOG6rcOZ4bucM+G7sOG6q+G7nDI1xah74buc4bqrPmLDoEDhu5w9eyxi4buc4bqr4bqtXeG7nOG7uC40PuG7nOG7h3s6M+G7nD3hurnhurc0POG7nD7DoeG7nD5Z4bql4bucQFnhuqXhu5zhu5fDveG7hsWpxqEt4buew5rhu5w9w51i4buc4bqrezo04bucPeG6ueG6s0Dhu5xAWeG6peG7nOG6pT4l4bql4buc4buH4bqxe+G7nOG6qzo04bucPDh74buc4buL4buHeynDmeG7h3vhuq3DkuG7nOG6q+G6rTU0POG7nOG7uMOge+G7nEDGrzQ+4buc4bqpw6Dhu5xAw5nhu5wz4buwQOG7nOG7uC40PuG7nOG6teG7nDThurnhurFA4bucNOG7pmbhu5w94buo4buc4buH4bq54bqz4bqr4buc4bqnYuG7pOG7nDPDoEDhu5xS4bui4bui4buM4bui4bui4bui4bucNDzhurnhurd74buM4buQL+G6peG7kuG7kOG6peG7nEAyw5nhuqnhuqnEqOG7muG6peG7lTUjZuG7muG7kuG7kHszPOG7nEAyw5nhuqnhuqnEqOG7mkAz4bqpLeG6pT414bqrNeG7muG7nOG6q3vhuqsyJMSo4buaeTzDmeG7nOG6rcOZ4bucM+G7sOG6q+G7nOG6qz5iw6BA4bucPXssYuG7nOG6q+G6rV3hu5zhu5fDveG7hsWpxqEt4buew5rhu5w9w51i4buc4bqrezo04bucPeG6ueG6s0Dhu5xAWeG6peG7nOG6pT4l4bql4bucPls0PuG7nMavND7hu5zhu57hu5rhu5zhuqnhuq1AxKjhu5ovL0Dhu4zhu7jDmTXhuqs+w5k0Pj41w5nhu4zhu4c0L3szPC8jJOG6qTHhuqs14bqlLzQk4buD4bqpL+G7oOG7ouG7oFAv4bueVFQjUuG7olRSUlJR4bqrVFLhu6BUMuG7nuG7jOG7gyThu7jhuqXhu5rhu5zDmTLhuqvEqOG7mnk8w5nhu5zhuq3DmeG7nDPhu7Dhuqvhu5zhuqs+YsOgQOG7nD17LGLhu5zhuqvhuq1d4buc4buXw73hu4bFqcahLeG7nsOa4bucPcOdYuG7nOG6q3s6NOG7nD3hurnhurNA4bucQFnhuqXhu5zhuqU+JeG6peG7muG7nCPDmeG6q8OZLeG6pT414bqrNS014bqtezx7NMOZMi3huqnhuq1AxKjhu5o+4bqr4bqr4bql4bqpTy8vQCM0ezM84buM4buHeyThuqs0w5kz4bqlMmLhuqnhu4zhu4c0L+G6q1Phu6Dhu6IvYuG6pTI1w5kjJCMv4bu4NTA1McOZL+G7oOG7ouG7oOG7ol/hu6JTX+G7nuG7ni/DmeG7h3spw5nhu4d74bqt4buMMOG6pTzhu5rhu5wv4buS4buL4buHeynDmeG7h3vhuq3hu5w94buo4bucPeG6ueG6s0Dhu5xAPmJmITThu5w9OzThu5xA4bukQOG7nOG7uC40PuG7nOG7h3suNOG7nOG7h+G7puG7nOG6pT43NDzhu5wxPuG7pDPhu5zhuqvFqHvhu5x5PMOZ4buM4bucw5VrND5P4buc4buVMjU1M+G7uCThuq08w5Thu5Av4bql4buS4buQ4bql4bucQDLDmeG6qeG6qcSo4bua4bql4buVNSNm4bua4buS4bqq4bqtNTQ84bucM+G6o+G6q+G7nOG6qz7DoTQ84bucQOG7pDXhu5zhu7jhu6Q14bucQD59w5Lhu5zhuqZiw6zhu5zhu5vDnWLhu5zhuqvhurnhu5zhuqvhuq3DqkDhu5zhuqt7O+G6peG7nHk8w5nhu5zDleG6rMahxanDucOU4bucQD414buc4bu4ezvhuqvhu5wyw6Hhu5zhuqs+YsOgQOG7nOG7i+G7h3spw5nhu4d74bqt4bucPcOdYuG7nOG6q3s6NOG7nD3hu6jhu5w94bq54bqzQOG7nEBiNDzhu5xAWeG6peG7nEA+NeG7nEDhu6RA4buc4bu4LjQ+4buc4buHey404buc4buH4bum4buc4bqlPjc0POG7nDE+4bukM+G7nOG6q+G6rTo04buc4bqrNeG7pjThu5zhuqdiw6BA4buM4buc4bqsxqHFqcO54bucMuG7puG7nD3huq804buc4buHXeG7nEBiNDzhu5xAWeG6peG7nDF7ND7hu5zhuqU+feG7nEA+NeG7nD41xajhuqvhu5w94bqjNDzhu5zhuqs+4bq/4bucNDw+ey4z4buc4bqrPmLDoEDhu5zhu4fhu6bhu5xANuG7nFLhu6JL4bucQMOj4buc4bqlPsOdNOG7nOG6q+G6rTU0POG7nOG6q+G7suG6peG7nD014bumNOG7nOG7lz4kM+G6rMOZ4bqt4bucLeG7nDQ+4bum4buc4bqpxq804buc4buFYlnhuqvhu5zhuqs+YsOgQOG7nOG7i+G7h3spw5nhu4d74bqt4buM4buQL+G6peG7kuG7kOG6peG7nEAyw5nhuqnhuqnEqOG7muG6peG7lTUjZuG7muG7kuG7leG6o+G7nEbhu5zhuqs74buceTzDmeG7nD3hu6jhu5xAWeG6peG7nOG6pT4l4bql4bucQD414buc4bqrPmLDoEDhu5zhu4vhu4d7KcOZ4buHe+G6reG7nOG6qz4kNeG7nDPhuqPhuqvhu5zhuqdi4buk4buc4bqr4bqtWzQ+4buc4bqlPjrhu5xAPmLhu7Q04bucPeG7rkDhu5zhu7h7LuG6q+G7nD3hurnhurNA4buc4bqrPsOqQOG7nD57LjThu5zhuqvhuq01NDzhu5zhuqs+4bq3e+G7nDx7w5k04bucNDzhu7A04buM4buc4buX4bukQOG7nD41xajhuqvhu5w94bqjNDzhu5zhuqs+4bq/4bucNDw+ey4z4buc4bqrxah74buceTzDmeG7nCN7KDThu5zhuq3DmeG7nDQ+w5k0PuG7nOG7h+G7puG7nEA24buc4bqnYmbhu5wzw6Hhu5w0Pjnhu5w+4bqvNOG7nOG6qTXhu5zhu4fhurF74bucND57LGLhu5zhuqdiw6BA4bucPHvDmeG7nDE+4bukQMOS4buc4bqr4bqtNTQ84buc4bu4w6B74bucQMavND7hu5wjXUA+4buc4bu4LjQ+4bucPcOZNDzhu5wyWGbhu5wyw5k04buc4buH4bqxe+G7nOG6q8OgQOG7nD3huqPhu5w0PsOZND7hu4zhu5Av4bql4buS4buQ4bql4bucQDLDmeG6qeG6qcSo4bua4bql4buVNSNm4bua4buS4bun4bqhe+G7nOG6q2LDnTThu5zhuqvhuq3hurnhurFAw5Lhu5w0POG6ueG6t3vhu5w94bq7NDzhu5w9w51i4buc4bqsxqHFqcO54bucdnvhuq17MjLhu5zGoTN74bqr4bqteyThu4fhu5xAPjXhu5zhu7h7O+G6q8OS4buc4buXPiQz4bqsw5nhuq3hu5xANuG7nDE74bucPjXFqEA+4buc4bqpxq804buc4buFYlnhuqvhu5w9ZeG7nOG6qz5iw6BA4bucPSHhu5w9eyxi4buc4bqr4bqtXeG7nEA+NeG7nDE+NcavNDzhu5xT4bui4buM4bui4bui4bui4bucNDzhurnhurd74bucM8SDe+G7nOG6qz7hu6Q0POG7jOG7nOG6qj4kNeG7nMOhNDzhu5zGoTN74bqr4bqteyThu4fDkuG7nEA24bucPuG6rzThu5zhu57hu6Lhu5zhuqdiw6BA4bucPHvDmeG7nD3hu6jhu5w9LOG7nDQ8Pl3hu5wzYsOZ4buc4bqrPmLDoEDhu5zhu4vhu4d7KcOZ4buHe+G6reG7nEBlw5nhu5x5PMOZ4buM4buQL+G6peG7kuG7kOG6peG7nEAyw5nhuqnhuqnEqOG7muG6peG7lTUjZuG7muG7kuG7huG6sXvhu5w+4bqvNOG7nFLhu6Lhu6Lhu4zhu6Lhu6Lhu6Lhu5zhuqvhuq3hurnhurc0POG7nD7hurPhuqXDkuG7nHk8w5nhu5w9w5k0POG7nOG7hTvhuqXhu5zhuqs+4bq74bucUOG7nOG6q+G6rTo04buc4bqrPjvhu5w8e+G6sXvhu5zhu4cs4buc4bqpw6Dhu5xAw5nhu5wz4buwQOG7nOG7uC40PuG7nOG7l8O94buGxanGoS3hu57DmuG7jOG7nOG6qmJm4bucND57OjTDkuG7nDThurnhurFA4bucNOG7pmbhu5wz4bqxe+G7nEA+IuG7nDw+e+G7nDQ+4buyNOG7nD7huq804bucU+G7jFLhu6Lhu6Lhu5xAw5nhu5zhuqvhur/hu5zhu4c1NDzDkuG7nDPhuqPhuqvhu5zhuqvDreG7nDIu4buc4bqr4bq54bqvNDzhu5w9w6B74buc4bqrPlnhuqXhu5zhuqk14buc4buH4bqxe+G7nDQ+eyxi4buc4bqnYsOgQOG7nDx7w5nhu5wxPuG7pEDhu4zhu5zhu6d7LjThu5w0PnssYuG7nD1dw5nhu5zhuqU+4bq54bqvNDzDkuG7nOG6q+G6rTU0POG7nD024bucQDbhu5zhuqs+ZeG7nD3DoeG7nHg14bqpMeG7h8OZw5Lhu5w94buo4buc4bu44buw4bqr4bucPcOdYuG7nCPDouG7nOG7uDnhu5xA4bukQOG7nOG7uHsuNOG7nOG6pT7hu6ThuqXhu5zhuqU+NTQ84buc4bqrOcOZ4bucPeG6ueG6s0Dhu5zhu6ThuqXhu5w94buu4bqr4bucPSHhu5wxPsOgNDzhu5xAPjvhu5wjXUA+4buc4bu4LjQ+4buML+G7jOG7kC/huqXhu5Lhu5DhuqXhu5xAMsOZ4bqp4bqpxKjhu5rhuqXhu4ti4bqrPjXhuq3hu5rhu5LDleG7hnsk4bqrNMOZMyvDlOG7kC/huqXhu5I=

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh